Ep 1734129 B1
Total Page:16
File Type:pdf, Size:1020Kb
(19) TZZ_¥_ _T (11) EP 1 734 129 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: C12P 7/24 (2006.01) C12P 17/06 (2006.01) 24.02.2016 Bulletin 2016/08 (86) International application number: (21) Application number: 05727417.7 PCT/JP2005/005719 (22) Date of filing: 28.03.2005 (87) International publication number: WO 2005/098012 (20.10.2005 Gazette 2005/42) (54) PROCESS FOR PRODUCTION OF CHIRAL HYDROXYALDEHYDES VERFAHREN ZUR HERSTELLUNG CHIRALER HYDROXYALDEHYDE PROCÉDÉ DE FABRICATION D’HYDROXYALDÉHYDES CHIRALES (84) Designated Contracting States: (56) References cited: AT BE BG CH CY CZ DE DK EE ES FI FR GB GR WO-A2-03/006656 HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR • SAKURABA, H. ET AL.: "The First Crystal (30) Priority: 29.03.2004 JP 2004095263 Structure of Archaeal Aldolase. unique tetrameric structure of (43) Date of publication of application: 2-deoxy-D-ribose-5-phosphate aldolase from the 20.12.2006 Bulletin 2006/51 hyperthermophilic Archaea Aeropyrum pernix" JOURNAL OF BIOLOGICAL CHEMISTRY, vol. (73) Proprietor: Mitsui Chemicals, Inc. 278, no. 12, 21 March 2003 (2003-03-21), pages Tokyo 105-7117 (JP) 10799-10806, XP002596667 • SAKURABA, H. ET AL.: "Sequential Aldol (72) Inventors: Condensation Catalyzed by Hyperthermophilic • MATSUMOTO, Kazuya, 2-Deoxy-D-Ribose-5-Phosphate Aldolase" c/o Mitsui Chemicals, Inc. APPLIED AND ENVIRONMENTAL Mobara-shi, Chiba 2970017 (JP) MICROBIOLOGY, vol. 73, no. 22, November 2007 • KAZUNO, Yasushi, (2007-11), pages 7427-7434, XP002596660 c/o Mitsui Chemicals, Inc. • GIJSEN H. ET AL.: ’Unprecedented Asymmetric Mobara-shi, Chiba 2970017 (JP) Aldol Reactions with Three Aldehyde Substrates • HIGASHIMURA, Norikazu, Catalyzed by 2-Deoxyribose-5-phosphate c/o Mitsui Chemicals, Inc. Aldolase.’ JOURNAL OF THE AMERICAN Mobara-shi, Chiba 2970017 (JP) CHEMICAL SOCIETY. vol. 116, 1994, pages 8422 • OHSHIMA, Toshihisa, - 8423, XP002128323 c/o Tokushima University • DATABASE NCBI ENTREZ PROTEIN Q9X1P5, 15 Tokushima-shi, Tokushima 7708506 (JP) February 2000 ’Deoxyribose-Phospate Aldolase • SAKURABA, Haruhiko, (Phospodeoxyboaldolase) (Deoxyriboalase).’, c/o Tokushima Univercity XP002990107 Tokushima-shi, Tokushima 7708506 (JP) • DATABASE NCBI ENTREZ PROTEIN Q8ZXK7, 15 June 2002 ’Probable deoxyribos-phosphate (74) Representative: Wills, Andrew Jonathan aldolase (Phosphodeoxyboaldolase) Mewburn Ellis LLP (Deoxycriboaldolase).’, XP002990108 City Tower 40 Basinghall Street London EC2V 5DE (GB) Note: Within nine months of the publication of the mention of the grant of the European patent in the European Patent Bulletin, any person may give notice to the European Patent Office of opposition to that patent, in accordance with the Implementing Regulations. Notice of opposition shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention). EP 1 734 129 B1 Printed by Jouve, 75001 PARIS (FR) EP 1 734 129 B1 Description Technical Field 5 [0001] The present invention relates to a process for producing a hydroxyaldehyde compound, comprising conducting aldol condensation of a substituted or unsubstituted aliphatic aldehyde compound having 2 to 6 carbon atoms with a single molecule of acetaldehyde, or by further conducting aldol condensation with a second acetaldehyde molecule to produce the hydroxyaldehyde compound having the number of carbon atoms increased by two or four compared to that of the starting aliphatic aldehyde compound. 10 Background Art [0002] D-2-deoxyribose-5-phosphate aldolase (EC4.1.2.4) (hereinafter, referred to as "DERA" for short) is a generic name for an enzyme which catalyzes aldol condensation which synthesizes D-2-deoxyribose-5-phosphate from glycer- 15 aldehyde-3-phosphate and acetaldehyde as substrates, and a reverse reaction thereof (retroaldol reaction). Reactivity of Escherichia coli (E. coli)-derived DERA was analyzed in detail, and reported to have a relatively wide spectrum of substrate-specificity, thus catalyze aldol condensation of various aldehydes to produce chiral hydroxyaldehydes (See Non-Patent Document 1). [0003] As shown in the reaction scheme of Fig. 1, it is reported that in the aldol condensation of various aldehydes 20 with acetaldehyde, a compound having the number of carbon atoms increased by four compared to that of the starting aldehyde is obtained by subjecting a hydroxyaldehyde, which is resulted from aldol condensation of a single molecule of aldehyde and a single molecule of acetaldehyde, to further aldol condensation with another single molecule of acetal- dehyde. It has been reported that this compound resulting from aldol condensation with two molecules of acetaldehyde is produced as the main reaction product because the compound takes a stable lactol structure (See Non-Patent Doc- 25 ument 2). [0004] However, the conventionally known activity of DERA to various aldehydes as described above is reported to be extremely low, and to be less than 1/100 of the activity with respect to glyceraldehyde-3-phosphate and acetaldehyde, which are the original substrates (See Non-Patent Document 3). It is also reported that aldehydes are strong inhibitors to enzymes, and DERA is also inhibited by aldehydes (See Non-Patent Document 4). Accordingly, aldol condensation 30 of these aldehydes requires a large amount of the enzyme. For example, Patent Document 1 described above discloses the synthesis of a 2,4,6-trideoxyhexose derivative via a 4-substituted-3-hydroxybutylaldehyde intermediate, wherein an increased amount of D-2-deoxyribose-5-phosphate aldolase to the degree of 125 U/mmol to 150 U/mmol was added, relative to the total number of moles of the substrates, namely, acetaldehyde and substituted acetaldehyde. Similarly, it is believed that even the reaction of condensation one acetaldehyde molecule requires the addition of an increased 35 amount of the enzyme to the degree of 80 U/mmol to 100 U/mmol. Furthermore, for the purpose of alleviating inhibition, multiple addition of aldehydes and DERA is also being investigated (See Patent Document 2). [0005] The aldol condensation reaction by DERA has another problem in controlling the number of acetaldehyde molecules to be condensed. Although the attempts of changing the concentration ratio of two aldehydes subjected to the aldol condensation or changing the amount of enzyme have been made, it has been difficult to control the number 40 of acetaldehyde molecule, only except for the case of aldol condensation of several aldehydes having hydroxyl groups on the α-position or β-position, with acetaldehyde (See Non-Patent Document 5, Non-Patent Document 6 and Patent Document 3). Due to these problems, it has been difficult to practicalize the aldol condensation by DERA. [0006] From the viewpoint of highly stable DERA, a thermally stable DERA which is derived from a hyperthermophilic bacterium, Aeropyrum pernix, has been reported (See Patent Document 4). This enzyme is reported to have high thermal 45 stability and high stability against polar organic solvents such as methanol, ethanol and the like (See Non-Patent Doc- ument 8). Additionally, DERA derived from thermophilic bacteria such as Thermotoga maritima, Thermus thermophilus and the like have been reported, but nothing is reported concerning the stability against aldehydes, activity on aldol condensation or the like of these thermophilic bacterium-derived DERA (See Non-Patent Document 9). [0007] In general, a thermophilic bacterium-derived enzyme exhibits high activity in a high temperature region near 50 the original growth temperature, and has significantly low activity in the normal temperature region. In the case of the aldol condensation inwhich a highly reactive compound such as aldehyde is used as the substrate, a reaction in a high temperature region is predicted to be accompanied by various side reactions. Thus, it is necessary to perform the aldol reaction under low temperature conditions, and therefore, it is generally inconceivable to use a thermophilic bacterium- derived DERA for the reaction. Furthermore, it was difficult to deduce that the enzyme would have high stability against 55 aldehydes, merely from the fact that the enzyme has high thermal stability, since aldehydes have a property of being reactive to the lysine residue or the like that are present in proteins. [Patent Document 1] US Patent No. 5,795,749 2 EP 1 734 129 B1 [Patent Document 2] WO 03/006656 [Patent Document 3] WO 03/077868 [Patent Document 4] JP-A No. 2003-250553 [Non-Patent Document 1] J. Am. Chem. Soc., Vol. 112, pp. 2013-2014 (1990) 5 [Non-Patent Document 2] J. Am. Chem. Soc., Vol. 116, pp. 8422-8423 (1994) [Non-Patent Document 3] J. Am. Chem. Soc., Vol. 114, pp. 741-748 (1992) [Non-Patent Document 4] PNAS, Vol. 101, pp. 5788-5793 (2004) [Non-Patent Document 5] J. Am: Chem. Soc., Vol. 117, pp. 3333-3339 (1995) [Non-Patent Document 6] Angeu. Chem. Int. Ed., Vol. 39, pp. 1352-1374 (2000) 10 [Non-Patent Document 7] J. Am. Chem. Soc., Vol. 114, pp. 741-748 (1992) [Non-Patent Document 8] J. Biol. Chem., Vol. 278, pp. 10799-10806 (2003) [Non-Patent Document 9] J. Mol. Biol., Vol. 343, pp. 1019-1034 (2004) Disclosure of the Invention 15 [0008] It is an object of the present invention to provide an industrial process for producing hydroxyaldehydes efficiently, by solving the problems of conventional DERA, such as low stability against aldehydes, low catalytic activity for aldol condensation, and the difficulty of controlling the number of acetaldehyde molecules